Alnylam Pharmaceuticals
ALNY
#646
Rank
NZ$53.89 B
Marketcap
$417.88
Share price
-0.77%
Change (1 day)
55.90%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Number of shares outstanding for Alnylam Pharmaceuticals (ALNY)

Number of shares outstanding as of November 2024 : 128,590,000

According to Alnylam Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 128,590,000. At the end of 2024 the company had 128,590,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Alnylam Pharmaceuticals from 2003 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20240.12 B2.37%
20230.12 B1.9%
20220.12 B2.92%
20210.11 B3.01%
20200.11 B4.05%
20190.11 B10.57%
20180.10 B5.12%
201796.13 M11.99%
201685.84 M1.15%
201584.87 M10.28%
201476.95 M22.33%
201362.9 M21.4%
201251.82 M21.49%
201142.65 M1.26%
201042.12 M1%
200941.7 M1.24%
200841.19 M5.57%
200739.02 M21.49%
200632.12 M53.59%
200520.91 M7.21%
200419.5 M2209.85%
20030.84 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
124,199,000-3.41%๐Ÿ‡บ๐Ÿ‡ธ USA
108,100,000-15.93%๐Ÿ‡บ๐Ÿ‡ธ USA
94,618,000-26.42%๐Ÿ‡บ๐Ÿ‡ธ USA
697,211,592 442.20%๐Ÿ‡บ๐Ÿ‡ธ USA
64,465,185-49.87%๐Ÿ‡บ๐Ÿ‡ธ USA
2,012,000,000 1,464.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
2,506,000,000 1,848.83%๐Ÿ‡ซ๐Ÿ‡ท France
1,133,000,000 781.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel